Dennis M. McGrath
Director, CITIUS ONCOLOGY, INC.
Since Jan 1, 2024.
- Alpha ID
- alpha:person:dennis-m-mcgrath
- Record version
- vpublic-0:d751713988987e9331980363e24189ce, published Sep 2, 2026
- Newest evidence
- Apr 30, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- Current role
- DirectorSince Jan 1, 2024
- Board seats
- 4CITIUS ONCOLOGY, INC., Citius Pharmaceuticals, Inc.
- Committee seats
- 0None published
- Published claims
- 258 distinct sources
- Evidence records
- 160 pinned
- Source conflicts
- 0None open
Built from 8 distinct sources and 16 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
Public-role record. Alpha publishes facts about this person's role at an organization in the public Registry, drawn from regulatory filings and company statements, and nothing about private life. Any person or agent may read it. The subject can correct, dispute, or object. How this works
DIRECTOR APPOINTED
Dennis M. McGrath seat on CITIUS ONCOLOGY, INC., effective 2024-01-01.
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- EvidencecorroboratedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Board service
EvidenceSeats held as a director, as published in the cited sources.
CITIUS ONCOLOGY, INC. CurrentDirector, 2024 to presentOpen recordCitius Pharmaceuticals, Inc. CurrentDirector, 2023 to presentOpen recordDarioHealth Corp. CurrentDirector, 2013 to presentOpen recordPAVmed Inc. CurrentDirector, Current · dates not publishedOpen recordCommittee experience
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Work experience
Evidence- 2026 to end not publishedExecutive title: Chief Financial OfficerOrganization not publishedE2
- 2026 to end not publishedExecutive title: President and Chief Financial OfficerOrganization not publishedE1
- 2025 to end not publishedExecutive title: DirectorOrganization not publishedE3E8
- Dates not publishedExecutive title: Executive Vice President and Chief Financial OfficerOrganization not publishedE9
Education, credentials, and certifications
EvidenceNo education, credentials, or certifications are published in this record.
No published claims
No education, credentials, or certifications are published in this record.
AI, cyber, and technology accountability
EvidenceAuthority to act
Evidence and agent registryWho may act on this authority. An agent about to transact, or one presenting itself as acting under this authority, checks these Claims first.
Compensation and holdings
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Conflicts and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Only permissioned public claims and evidence are included.Only permissioned public claims and evidence are included.
- Absence of a claim is not evidence that the underlying fact is false.Absence of a claim is not evidence that the underlying fact is false.
- Public retrieval does not grant model-training or redistribution rights.Public retrieval does not grant model-training or redistribution rights.
- Private relationships and Council activity are excluded.Private relationships and Council activity are excluded.
Linked records
Same claim, both recordsEach relationship is one Claim rendered on every record it connects.
- CITIUS ONCOLOGY, INC.Director, 2024 to presentperson:dennis-m-mcgrath:role:1
- Citius Pharmaceuticals, Inc.Director, 2023 to presentperson:dennis-m-mcgrath:role:2
- DarioHealth Corp.Director, 2013 to presentperson:dennis-m-mcgrath:role:3
- PAVmed Inc.Director, Current · dates not publishedperson:dennis-m-mcgrath:role:4
- Organization not publishedExecutive title: Chief Financial Officer, 2026 to end not published; Executive title: President and Chief Financial Officer, 2026 to end not published; Executive title: Director, 2025 to end not published; Executive title: Executive Vice President and Chief Financial Officer, Dates not publishedperson:dennis-m-mcgrath:executive_title:15, person:dennis-m-mcgrath:executive_title:18 +2
Subject and corrections
Public-role doctrineThis record exists because the subject holds a public role. The subject can claim the profile, correct, dispute, or object. Subject statements appear as their own assertion state and never overwrite the evidence.
- Basis
- Public role at an organization in the published Registry
- Sources
- 16 evidence records cited. 0 with redistribution rights.
- Never published
- Home address, family, personal contacts, health, and history unrelated to the public role
- Profile claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
If the subject claims the profile, their statements appear as their own assertion state, subject attested. They never overwrite the evidence.
Evidence
Authority and rights- E1SEC EDGAR. sec filing. Published Apr 30, 2026. Retrieved May 16, 2026. Cited by 6 Claims.
- E2SEC EDGAR. sec filing. Published Apr 30, 2026. Retrieved May 16, 2026. Cited by 2 Claims.
- E3SEC EDGAR. sec filing. Published Mar 19, 2026. Retrieved May 16, 2026. Cited by 2 Claims.
- E4SEC EDGAR. sec filing. Published Feb 24, 2026. Retrieved May 16, 2026. Cited by 5 Claims.
- E5SEC EDGAR. sec filing. Published Feb 24, 2026. Retrieved May 15, 2026. Cited by 2 Claims.
- E6sec proxy. Published Feb 24, 2026. Retrieved Apr 25, 2026. Cited by 1 Claim.
- E7sec proxy. Published Feb 24, 2026. Retrieved Apr 25, 2026. Cited by 1 Claim.
- E8SEC EDGAR. sec filing. Published Dec 23, 2025. Retrieved May 16, 2026. Cited by 2 Claims.
- E9SEC EDGAR. sec filing. Published Dec 22, 2025. Retrieved May 15, 2026. Cited by 4 Claims.
- E10sec proxy. Published Dec 22, 2025. Retrieved Apr 25, 2026. Cited by 1 Claim.
- E11SEC EDGAR. sec filing. Published Sep 26, 2025. Retrieved May 15, 2026. Cited by 2 Claims.
- E12sec proxy. Published Sep 26, 2025. Retrieved Apr 28, 2026. Cited by 1 Claim.
- E13public source. Cited by 1 Claim.
- E14public source. Cited by 1 Claim.
- E15public source. Cited by 1 Claim.
- E16public source. Cited by 1 Claim.
What changed in version public-0:d751713988987e9331980363e24189ce
vpublic-0:d751713988987e9331980363e24189ce published Sep 2, 2026- Dennis M. McGrath seat on CITIUS ONCOLOGY, INC., effective 2024-01-01.
- Dennis M. McGrath seat on Citius Pharmaceuticals, Inc., effective 2023-01-01.
- Dennis M. McGrath seat on DarioHealth Corp., effective 2013-01-01.



